您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Cagrilintide
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Cagrilintide
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CAS NO:1415456-99-3
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
Cagrilintide 是一种在研的新型长效酰化胰淀素类似物,作为非选择性的胰淀素受体 (AMYR) 和 降钙素 G 蛋白偶联受体 (CTR) 激动剂。Cagrilintide 可显着减轻体重并减少食物摄入。Cagrilintide 具有肥胖研究潜力。
生物活性

Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselectiveamylin receptors (AMYR)andcalcitoninG protein-coupled receptor (CTR)agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity[1][2][3].

体内研究
(In Vivo)

Cagrilintide (compound 23) (0.1, 1, 3, 10, 30 nmol/kg; s.c.) reduces food intake in the rat[2].
Cagrilintide (10 nmol/kg; i.v. or s.c.) shows good pharmacokinetic parameters[2].

Animal Model:12 weeks, 400 g Sprague Dawley male rats[2]
Dosage:0.1, 1, 3, 10, 30 nmol/kg
Administration:S.c.; once for 80 h
Result:Reduced food intake in the rat for several days at doses in the range of 1-10 nmol/kg.
Animal Model:12 weeks, 400 g Sprague Dawley male rats[2]
Dosage:10 nmol/kg
Administration:I.v.; s.c.
Result:Showed good pharmacokinetic parameters with T1/2of 20±2, 27±3 h for i.v. and s.c., respectively.
Clinical Trial
CAS 号

1415456-99-3

Sequence Shortening

{Ggu}KCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP (Disulfide bridge:Cys3-Cys8)

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.